• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Dexcom, RxFood Ally for AI-Based Nutrition, Glycemic Control in Diabetes Management

    Sharon Levita Joins ForSight Robotics as CFO

    PECA Labs Names Three New Board Members

    Astellas, Eko Health Collaborate on Heart Failure Detection Tech

    Sherri Ferstler Joins Tactile Medical as Senior Sales VP
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Cirtec Medical

    Halkey-Roberts Corporation

    Medbio LLC

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Cirtec Medical

    Halkey-Roberts Corporation

    Medbio LLC

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    19. Olympus Corp.

    ...

    19. Olympus Corp.
    07.26.18
    $5.2 Billion ($6.7B total)

    KEY EXECUTIVES:
    Hiroyuki Sasa, President and Representative Director
    Shiro Hiruta, Outside Director (Chairman of the Board)
    Yasuo Takeuchi, Director, VP, and, CFO
    Nacho Abia, President and CEO, Olympus Corporation of the Americas
    Akihiro Taguchi, Head of Sales & Marketing Group/Medical Business Managing Officer
    Katsuyuki Saito, Head of Gastrointestinal and Respiratory Business Unit
    Tomohisa Sakurai, Head of General Surgery Business Unit
    Minoru Okabe, Head of Urology/Gynecology Business Unit
    Georg Schloer, Head of Ear, Nose, and Throat Business Unit
    Yoshihito Shimizu, Head of Medical Service Business Unit

    NO. OF EMPLOYEES: 34,687 (total)

    GLOBAL HEADQUARTERS: Shinjuku-ku, Tokyo, Japan

    It is often said the cover-up is worse than the lie itself.

    That may be an extreme read of the 2013 Olympus scope infection outbreak, but given findings that have since emerged, it certainly could apply. In July 2017, only a few months after the close of Olympus’ 2017 fiscal year (which ran April 1, 2016 to March 31, 2017), a jury had ordered the company to pay a Seattle hospital $6.6 million in damages tied to the superbug outbreak linked to the firm’s duodenoscope. The jury also indicated the hospital was to pay $1 million to the deceased patient’s family—Richard Bigler’s widow, Theresa Bigler, and Theresa’s four children. The case was the first to go to trial involving the deadly duodenoscope-related infections. More than 25 lawsuits have been filed against Olympus due to the outbreak.

    The jury in the Bigler case also indicated it did not find the scope was unsafe as designed—an important win for Olympus. That finding could be in jeopardy though.

    According to a January 2018 report in The Washington Post, King County Superior Court Judge Steve Rosen (located in Seattle) said Olympus failed to properly disclose internal emails relevant to the case. The emails, which originated from as far back as 2008, raised safety concerns about a redesigned medical scope, approximately five years prior to the superbug outbreaks. Judge Rosen ordered a new trial for Theresa Bigler’s case.

    While Olympus shared the relevant emails with the plaintiffs, they were not translated from Japanese, as required. Within those emails were possible indications the company was aware of potential design issues, even before the scopes entered the market in 2010.

    “Olympus robbed the Bigler family of a full and fair trial. They hid the documents and hid the witnesses,” said the plaintiff’s attorney, David Beninger, whose team found the emails after an Olympus executive mentioned hospital tests during the first trial, in the Post’s report. “The family is grateful they will get another chance to hold Olympus accountable.”


    ANALYST INSIGHTS: It is often that Japanese healthcare companies that do well in Japan struggle to perform in the U.S. Olympus is an exception to this rule. With strong North American leadership in place, watch Olympus continue steady growth through focus on execution and bolt-on acquisitions.

    —Dave Sheppard, Co-Founder and Principal, MedWorld Advisors



    Also according to the Post article, the emails revealed the fact that Olympus gave a prototype version of the scope to several hospitals and doctors in Europe and the United States for a trial run prior to its market launch in 2010. An unidentified nurse at one of the facilities noted a potential issue with cleaning the tip of the reusable scope. The feedback resulted in further messages among Olympus employees, discussing the potential downside of adding a cleaning brush to the product. Ultimately, the brush was not included at launch; rather, following the superbug outbreak, Olympus issued a safety alert that indicated users should employ a cleaning brush.

    With translation of all the emails and details still waiting to be uncovered, it is unclear where these superbug cases will end up. But from what’s already been revealed, the outcome doesn’t look good for Olympus.

    Of course, these revelations came after the 2016 discovery that the company had decided against issuing a warning to U.S. hospitals in February 2013 about the scope-related infections. According to a Los Angeles Times report, a senior executive at the Olympus headquarters in Tokyo ordered U.S. managers not to inform American hospitals of infections that had occurred in Dutch, French, and other U.S. facilities. An alert was issued to European customers, but the U.S. hospitals were not alerted until the aforementioned announcement in 2015.

    “We are very troubled by the now very clear facts that Olympus in Japan knew of the infection problems with their duodenoscopes long before the outbreaks we saw in America, and chose not to warn physicians,” Dr. Andrew Ross, section chief of gastroenterology at Virginia Mason Medical Center, said in the Los Angeles Times report.

    Perhaps seeing the writing on the wall, Olympus issued a voluntary recall of its TJF-Q180V duodenoscope models from U.S. hospitals. It performed a redesign and updated cleaning procedures; the new offering was cleared by the FDA in the same month.

    “We have made it a top priority to improve the safety of duodenoscopes and help protect patients from bacterial infections associated with these medical devices,” William Maisel, M.D., M.P.H., deputy director for science and chief scientist in the FDA’s Center for Devices and Radiological Health, said in a Jan. 15 FDA news release announcing the clearance. “The Olympus TJF-Q180V’s new design, as well as the new annual inspection program, is intended to reduce the risk of fluid leakage into the elevator channel, which in turn can reduce patient exposure to bacteria and other potential infections.”

    Unfortunately, the effort may not have been enough. In March 2017, in another Times report, it was announced that another infection outbreak may be tied to the redesigned scope. Five patients treated with the revised device all tested positive for the same bacteria. According to the newspaper’s report, Lawrence Muscarella, a medical safety expert in Montgomeryville, Pa., said the outbreak raises questions about whether Olympus’ recall and replacement of the mechanism was enough to keep patients safe. It was still uncertain if the hospital followed the updated cleaning procedures.

    The entire debacle casts a significant shadow over Olympus, which saw its net sales figure decline in fiscal 2017, and the situation doesn’t appear to be one that will end soon.

    The company posted 748 billion yen in its 2017 fiscal year, down 7 percent over 2016’s 805 billion yen. The figure represents the third lowest sales total in the last 10 years, only surpassing 2013 (which was only 4 billion yen less) and 2014. The company’s annual report did note, however, that if the impacts of foreign exchange influences were excluded, net sales would have risen 2 percent. Apparently, the bad press from the duodenoscopes-related infections have not scared off customers.

    The overwhelming majority of the 2017 fiscal year sales resulted from Olympus’ Medical Business, which reported 575.3 billion yen (76.9 percent of total company sales). The remaining businesses—Scientific Solutions (products and services supporting scientific research, pathological diagnoses, and inspections of manufacturing and social infrastructure), Imaging (primarily mirrorless cameras), and Others—accounted for the rest of the sales total, posting a combined 172.8 billion yen.

    The Medical Business had previously gone through a reorganization that transformed the company’s portfolio within the business from three divisions—Gastrointestinal/Endoscopes, Endotherapy Devices, and Surgical Devices—into five.

    Representing Olympus’ core business, the Gastrointestinal and Respiratory Business Unit is credited with more than 70 percent share of the global gastrointestinal endoscope market, substantially leading competitors such as Fujifilm and Hoya. The division contributed 319.7 billion yen to the company’s total sales (55.6 percent). This performance was driven primarily by double digit sales growth of gastrointestinal endoscope products in China and other regions within Asia/Oceania. Additionally, North America produced double digit growth for endotherapy devices—an Olympus division that enjoys approximately 20 percent of the global market share.

    The General Surgery Business Unit encompasses the Surgical Imaging (20 to 25 percent global market share) and Surgical Energy Devices (18 to 20 percent share) divisions. In total, the Unit accounts for 14.1 percent of the firm’s sales total, which translated to 81.3 billion yen in FY17. While sales growth in Surgical Imaging was slower than anticipated, the Energy Devices segment experienced double-digit expansion in principal regions during the 2017 fiscal year.

    As its name indicates, the Urology/Gynecology Business is broken down into two segments. The Urology portion has a hold of approximately 30 percent of the global market, and Gynecology sees about 10 percent of the world’s share. At 61.8 billion yen, the business represents 10.7 percent of Olympus’ net 2017 sales. Exceeding the company’s own expectations, sales for the business were driven by strong performance in all regions due to demand for bipolar electrodes for benign prostatic hypertrophy and bladder tumor resection.

    Reflecting 2.8 percent of the company’s overall net sales in FY17, the Ear, Nose, and Throat Business Unit posted 16.1 billion yen to the firm’s total. Composing the unit is Laryngology, which holds 50 to 60 percent global market share, and Otolaryngology, which enjoys 10 to 15 percent share. Some of the sales can be attributed to the company’s successful efforts in helping move the community from fiberscopes to videoscopes. Further, the introduction of a 4K camera system bolstered revenue from the unit.

    Accounting for the remainder of the Medical Business’ 2017 fiscal year revenue is the Medical Services Business Unit. At 91.2 billion yen, the division accounts for 15.8 percent of Olympus’ overall net sales total. Its primary role is to support the other Medical Business units, accomplished through its approximately 200 medical equipment repair and service sites worldwide.
    Seeking to strengthen its position in some of its key treatment areas, Olympus also extended strategic partnerships with other medtech providers. First, in April (actually announced on the first day of the 2017 fiscal year), Olympus and Hitachi renewed their alliance involving endoscopic ultrasound. The agreement was originally with Aloka Co. Ltd. before that firm was acquired by Hitachi. The arrangement pairs the endoscopic knowledge of Olympus with the ultrasound technology of Aloka. The firms will coordinate R&D activities to ensure the systems remain compatible and to maintain high endoscopic ultrasound technology standards.

    About six weeks later, Olympus offered an update on its subsidiary’s (Olympus Respiratory America) partnership with VIDA Diagnostics Inc., a provider of precision pulmonary imaging. The alliance involves the treatment of acute and chronic conditions of the lung. The agreement will see both firms incorporate precision informatics into their current, as well as future, diagnostic and therapeutic procedural workflows to manage patients with pulmonary diseases. 
    Related Searches
    • surgical
    • medtech
    • 2013
    • olympus corporation of the americas
    Suggested For You
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products
    Fluid Management System Market to be Worth $23.2 Billion By 2028 Fluid Management System Market to be Worth $23.2 Billion By 2028
    MedTech Innovator Selects 20 Firms for Asia Pacific Accelerator MedTech Innovator Selects 20 Firms for Asia Pacific Accelerator
    Olympus Releases New Endobronchial Ultrasound Bronchoscope Olympus Releases New Endobronchial Ultrasound Bronchoscope
    Olympus Rolls Out Airway Mobilescopes Olympus Rolls Out Airway Mobilescopes
    Olympus Corporation Opens Facility in Westborough, MA Olympus Corporation Opens Facility in Westborough, MA
    Olympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz Olympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz
    Olympus Agrees to Acquire Quest Photonic Devices Olympus Agrees to Acquire Quest Photonic Devices
    Endoscopic Hemostasis Devices Market Valued at $730 Million Endoscopic Hemostasis Devices Market Valued at $730 Million
    Olympus and Hitachi Sign Five-Year Contract Olympus and Hitachi Sign Five-Year Contract
    Olympus Releases ScopeLocker Endoscope Storage Cabinet Olympus Releases ScopeLocker Endoscope Storage Cabinet
    Olympus Adds 3D, IR, Novel Light Tech to MIS Imaging Platform Olympus Adds 3D, IR, Novel Light Tech to MIS Imaging Platform
    Olympus Corporation to Acquire Veran Medical Technologies Olympus Corporation to Acquire Veran Medical Technologies
    Thirteen Percent Revenue Shortfall Expected in Capsule Endoscopes Market Thirteen Percent Revenue Shortfall Expected in Capsule Endoscopes Market

    Related Breaking News

    • MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021

      MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021

      Attendees of The MedTech Conference, powered by AdvaMed, will vote for the Grand Prize winner.
      MedTech Innovator 09.21.21

    • Surgical
      Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products

      Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products

      Deliver consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency.
      Olympus Corporation 09.21.21

    • Fluid Management System Market to be Worth $23.2 Billion By 2028

      Fluid Management System Market to be Worth $23.2 Billion By 2028

      North America dominated the global market for fluid management system in 2020 and will continue that dominance over the next seven years.
      Polaris Market Research 07.13.21


    • MedTech Innovator Selects 20 Firms for Asia Pacific Accelerator

      MedTech Innovator Selects 20 Firms for Asia Pacific Accelerator

      Finalist companies comprised of promising entrepreneurs from the Asia Pacific Region.
      Business Wire 06.22.21

    • Diagnostics
      Olympus Releases New Endobronchial Ultrasound Bronchoscope

      Olympus Releases New Endobronchial Ultrasound Bronchoscope

      The BF-UC190F aids physicians in diagnosing and staging lung cancer without surgery.
      Sam Brusco, Associate Editor 05.12.21

    Loading, Please Wait..

    Trending
    • A New Approach To Post-Market Surveillance
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • Cochlear Implant Study Underway At Mayo Clinic
    Breaking News
    • AIRAmed’s AIRAscore Cleared by FDA
    • Dexcom, RxFood Ally for AI-Based Nutrition, Glycemic Control in Diabetes Management
    • Sharon Levita Joins ForSight Robotics as CFO
    • PECA Labs Names Three New Board Members
    • Astellas, Eko Health Collaborate on Heart Failure Detection Tech
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitafoods Europe Relocates to Barcelona Starting 2025
    GOED Releases Sustainability Report for Omega-3s Industry
    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Introduces High-Flexibility Body Filler
    Axalta’s Brian Berube to Retire
    Masco Corporation Names Richard Westenberg VP, CFO
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dexcom, RxFood Ally for AI-Based Nutrition, Glycemic Control in Diabetes Management
    Sharon Levita Joins ForSight Robotics as CFO
    PECA Labs Names Three New Board Members
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valneva Signs $32M IXIARO Supply Pact with U.S. Government
    Charnwood Molecular Rebrands to Charnwood Discovery
    Pierre Fabre, Vernalis Enter Oncology Drug Discovery Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Bluebird and Pact Collective Partner to Drive Beauty Industry Toward Circularity
    Groupe Pochet Celebrates 400th Anniversary
    Ulta Beauty Launches Initiative to Spark National Conversation About Joy
    Happi

    Latest Breaking News From Happi

    Lipoid Kosmetik’s Mountain Tea Pro Wins BSB Innovation Award
    Attitude’s 'Paper Beats Plastic' Campaign Takes Over Los Angeles
    L'Oréal Invests in Chinese Biotech Company
    Ink World

    Latest Breaking News From Ink World

    Tetra Pak Joins Earthquake Relief Efforts in Morocco
    Packaging Printing Market Worth $433.4B by 2025: MarketsandMarkets
    Cooper Watson Acquires Tower Products
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Bobst to 'unwrap the future of flexible packaging' at open house
    IDENTCO brings new automated wire marking system to Mexico
    Maan Engineering chooses Vetaphone for linerless labels
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bone Health Technologies Adds Two New Board Directors
    MicroPort Orthopedics Announces Agenda & Speakers for Its Global Medial-Pivot Symposium
    Study Reveals Discovery of Unique Vertebral Stem Cells
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    LG Display Expands IT Industry Presence
    First Solar Breaks Ground on $1.1B, 3.5 GW Louisiana Manufacturing Facility
    HID to Showcase Future-Proof Solutions at GITEX 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login